Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109- Is this information wrong?
Summary
- Dr. Arnav Srivastava is an urologic oncology fellow at the University of Michigan. He obtained his MD, MPH from The Johns Hopkins University School of Medicine in Baltimore, MD. He then completed his urology residency at Rutgers Robert Wood Johnson University Hospital in New Brunswick, NJ.
He has clinical interests in urologic malignancies including prostate, bladder, and kidney cancer.
He has research interests in health services research, health economics, insurance design, and biomarker development.
He has more than 50 publications and over 1000 citings.
Education & Training
University of Michigan Health SystemFellowship, Urologic Surgical Oncology, 2023 - 2026
Rutgers Robert Wood Johnson Medical SchoolResidency, Urology, 2018 - 2023
Johns Hopkins University School of MedicineClass of 2017
Certifications & Licensure
MI State Medical License 2023 - 2026
NJ State Medical License 2019 - 2025
Publications & Presentations
PubMed
- Editorial Comment on "Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter Analysis".Rachel Passarelli, Arnav Srivastava> ;Urology. 2024 Apr 1
- 1 citationsComparing the rate of immunotherapy treatment change due to toxicity by sex.Chua, K., Liu, H., Schneider, B., Sterling, J., Singer, E., Kronstedt, S., Kaldany, A., Srivastava, A., Tarhini, A., Gatti-Mays, M., Gaughan, E., Hu-Lieskovan, S., Alj...> ;Cancer Reports. 2024 Feb 1
- Editorial Comment: Does Alexis Wound Protector/Retractor Reduce the Risk of Surgical Site Infections After Open Radical Cystectomy for Bladder Cancer? Results From a S...Alex Zhu, Arnav Srivastava> ;Urology. 2024 Feb 1
- Join now to see all
Press Mentions
Exploring Impact of Surgery Delays for Clinical Renal Cell Carcinoma Patients During the COVID-19 PandemicFebruary 11th, 2021
Similar Incidence of DNA Damage Response Pathway Alterations Between Localized and Metastatic Prostate CancerMay 3rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
